Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) — Cash Flow Reinvestment Rate
Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) has a Cash Flow Reinvestment Rate of 0.77x as of September 2024, reinvesting CN¥39.75 Million (capex CN¥19.88 Million plus investments CN¥-19.87 Million) from operating cash flow of CN¥51.50 Million. Explore Jiangsu Lianhuan Pharmaceutical Co Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jiangsu Lianhuan Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2002–2024)
Historical reinvestment intensity for Jiangsu Lianhuan Pharmaceutical Co Ltd across 20 annual periods. Also explore 600513 total asset value for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Jiangsu Lianhuan Pharmaceutical Co Ltd (2002–2024)
Year-by-year capital reinvestment analysis for Jiangsu Lianhuan Pharmaceutical Co Ltd. For live market cap and broader valuation context, see 600513 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 17.17x | CN¥184.85 Million | CN¥10.77 Million | CN¥184.84 Million | ▲ +1217.5% |
| 2023 | 1.30x | CN¥209.42 Million | CN¥160.70 Million | CN¥200.66 Million | ▼ -61.3% |
| 2022 | 3.37x | CN¥429.70 Million | CN¥127.59 Million | CN¥209.02 Million | ▲ +175.7% |
| 2021 | 1.22x | CN¥168.98 Million | CN¥138.34 Million | CN¥168.92 Million | ▼ -35.6% |
| 2020 | 1.90x | CN¥174.25 Million | CN¥91.94 Million | CN¥174.18 Million | ▼ -92.5% |
| 2017 | 25.42x | CN¥92.44 Million | CN¥3.64 Million | CN¥48.64 Million | ▲ +1876.3% |
| 2016 | 1.29x | CN¥90.42 Million | CN¥70.28 Million | CN¥46.21 Million | ▲ +180.9% |
| 2015 | 0.46x | CN¥28.45 Million | CN¥62.12 Million | CN¥27.41 Million | ▲ +36.2% |
| 2014 | 0.34x | CN¥23.37 Million | CN¥69.50 Million | CN¥23.37 Million | ▼ -59.5% |
| 2013 | 0.83x | CN¥30.85 Million | CN¥37.17 Million | CN¥30.85 Million | ▲ +123.3% |
| 2012 | 0.37x | CN¥6.30 Million | CN¥16.94 Million | CN¥6.30 Million | ▼ -53.0% |
| 2011 | 0.79x | CN¥18.98 Million | CN¥24.00 Million | CN¥18.98 Million | ▼ -35.0% |
| 2010 | 1.22x | CN¥10.26 Million | CN¥8.43 Million | CN¥10.26 Million | ▲ +26.8% |
| 2009 | 0.96x | CN¥13.29 Million | CN¥13.83 Million | CN¥13.29 Million | ▼ -44.6% |
| 2008 | 1.73x | CN¥30.25 Million | CN¥17.44 Million | CN¥30.25 Million | ▼ -1.0% |
| 2007 | 1.75x | CN¥14.08 Million | CN¥8.03 Million | CN¥14.08 Million | ▼ -49.5% |
| 2006 | 3.47x | CN¥35.19 Million | CN¥10.14 Million | CN¥35.19 Million | ▲ +4.9% |
| 2005 | 3.31x | CN¥12.65 Million | CN¥3.82 Million | CN¥12.65 Million | ▲ +114.2% |
| 2004 | 1.54x | CN¥5.24 Million | CN¥3.39 Million | CN¥5.24 Million | ▲ +397.1% |
| 2002 | 0.31x | CN¥5.97 Million | CN¥19.22 Million | CN¥5.97 Million | — |